Abstract
Despite long-standing promise and many known examples, antimicrobial peptides (AMPs) have failed, with few exceptions, to significantly impact human medicine. Impediments to the systemic activity of AMPs include proteolysis, host cell interactions, and serum protein binding, factors that are not often considered in the early stages of AMP development. Here we discuss how synthetic molecular evolution, iterative cycles of library design, and physiologically relevant screening can be used to evolve AMPs that do not have these impediments.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Agawa Y et al (1991) Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic a-helical model peptides of various chain lengths. J Biol Chem 266:20218–20222
Arias CA, Murray BE (2009) Antibiotic-resistant bugs in the 21st century – a clinical super-challenge. N Engl J Med 360:439–443
Boucher HW et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12
Centers For Disease Control (2014) Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
Chen CL, Strop P, Lebl M, Lam KS (1996) One bead-one compound combinatorial peptide library: different types of screening. Methods Enzymol 267:211–219
de Breij A et al (2018) The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 10(423):eaan4044
Deuss PJ, Arzumanov A, Williams DL, Gait MJ (2013) Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo. Org Biomol Chem 11:7621–7630
Dobson AJ, Purves J, Kamysz W, Rolff J (2013) Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One 8:e76521
Dooley CT et al (1994) An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. Science 266:2019–2022
Easton DM, Nijnik A, Mayer ML, Hancock RE (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 27:582–590
Fedders H, Podschun R, Leippe M (2010) The antimicrobial peptide Ci-MAM-A24 is highly active against multidrug-resistant and anaerobic bacteria pathogenic for humans. Int J Antimicrob Agents 36:264–266
Fjell CD, Hancock RE, Cherkasov A (2007) AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics 23:1148–1155
Fox JL (2013) Antimicrobial peptides stage a comeback. Nat Biotechnol 31:379–382
Frank R (2002) The SPOT-synthesis technique. synthetic peptide arrays on membrane supports – principles and applications. J Immunol Methods 267:13–26
Gordon YJ, Romanowski EG, McDermott AM (2005) A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30:505–515
Hamill P, Brown K, Jenssen H, Hancock RE (2008) Novel anti-infectives: is host defence the answer? Curr Opin Biotechnol 19:628–636
He L, Hoffmann AR, Serrano C, Hristova K, Wimley WC (2011) High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation. J Mol Biol 412:43–54
He J et al (2013) Direct cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides. J Biol Chem 288:29974–29986
Hilpert K, Volkmer-Engert R, Walter T, Hancock RE (2005) High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol 23:1008–1012
Humet M et al (2003) A positional scanning combinatorial library of peptoids as a source of biological active molecules: identification of antimicrobials. J Comb Chem 5:597–605
Joly V, Jidar K, Tatay M, Yeni P (2010) Enfuvirtide: from basic investigations to current clinical use. Expert Opin Pharmacother 11:2701–2713
Kauffman WB, Guha S, Wimley WC (2018) Synthetic molecular evolution of hybrid cell penetrating peptides. Nat Commun 9:2568
Kazemzadeh-Narbat M et al (2010) Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31:9519–9526
Krauson AJ, He J, Wimley WC (2012) Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening. J Am Chem Soc 134:12732–12741
Krauson AJ, He J, Hoffmann AR, Wimley AW, Wimley WC (2013) Synthetic molecular evolution of pore-forming peptides by iterative combinatorial library screening. ACS Chem Biol 8:823–831
Krauson AJ et al (2015) Conformational fine-tuning of pore-forming peptide potency and selectivity. J Am Chem Soc 137:16144–16152
Kulagina NV, Shaffer KM, Anderson GP, Ligler FS, Taitt CR (2006) Antimicrobial peptide-based array for Escherichia coli and Salmonella screening. Anal Chim Acta 575:9–15
Kulagina NV, Shaffer KM, Ligler FS, Taitt CR (2007) Antimicrobial peptides as new recognition molecules for screening challenging species. Sensors Actuators B Chem 121:150–157
LaBonte J, Lebbos J, Kirkpatrick P (2003) Enfuvirtide. Nat Rev Drug Discov 2:345–346
Lam KS et al (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature (London) 354:82–84
Li S et al (2018) Potent macromolecule-sized poration of lipid bilayers by the Macrolittins, a synthetically evolved family of pore-forming peptides. J Am Chem Soc 140:6441–6447
Marks JR, Placone J, Hristova K, Wimley WC (2011) Spontaneous membrane-translocating peptides by orthogonal high-throughput screening. J Am Chem Soc 133:8995–9004
Mechkarska M et al (2013) An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties. Peptides 50:153–159
Molhoek EM, van Dijk A, Veldhuizen EJ, Haagsman HP, Bikker FJ (2011) Improved proteolytic stability of chicken cathelicidin-2 derived peptides by D-amino acid substitutions and cyclization. Peptides 32:875–880
Moy TI et al (2009) High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 4:527–533
Nguyen LT et al (2010) Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PLoS One 5:e12684
Okada M, Natori S (1983) Purification and characterization of an antibacterial protein from haemolymph of Sarcophaga peregrina (flesh-fly) larvae. Biochem J 211:727–734
Otto M (2012) MRSA virulence and spread. Cell Microbiol 14:1513–1521
Park SC et al (2011) Synthetic diastereomeric-antimicrobial peptide: antibacterial activity against multiple drug-resistant clinical isolates. Biopolymers 96:130–136
Patterson-Delafield J, Szklarek D, Martinez RJ, Lehrer RI (1981) Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes. Infect Immun 31:723–731
Perron GG, Zasloff M, Bell G (2006) Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273:251–256
Peschel A (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol 10:179–186
Peschel A, Sahl HG (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4:529–536
Pollard JE et al (2012) In vitro evaluation of the potential for resistance development to ceragenin CSA-13. J Antimicrob Chemother 67:2665–2672
Poveda E, Briz V, Soriano V (2005) Enfuvirtide, the first fusion inhibitor to treat HIV infection. AIDS Rev 7:139–147
Qureshi NM, Coy DH, Garry RF, Henderson LA (1990) Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS 4:553–558
Rapaport D, Ovadia M, Shai Y (1995) A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J 14:5524–5531
Rathinakumar R, Wimley WC (2008) Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc 130:9849–9858
Rathinakumar R, Wimley WC (2010) High-throughput discovery of broad-spectrum peptide antibiotics. FASEB J 24:3232–3238
Rathinakumar R, Walkenhorst WF, Wimley WC (2009) Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc 131:7609–7617
Rausch JM, Marks JR, Wimley WC (2005) Rational combinatorial design of pore-forming beta-sheet peptides. Proc Natl Acad Sci U S A 102:10511–10515
Riedl S, Zweytick D, Lohner K (2011a) Membrane-active host defense peptides – challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164:766–781
Riedl S et al (2011b) In search of a novel target – phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim Biophys Acta 1808:2638–2645
Savini F et al (2017) Cell-density dependence of host-defense peptide activity and selectivity in the presence of host cells. ACS Chem Biol 12:52–56
Savini F, Bobone S, Roversi D, Mangoni M, Stella L (2018) From liposomes to cells: filling the gap between physicochemical and microbiological studies of the activity and selectivity of host-defense peptides. Pept Sci 110:e24041
Schlusselhuber M et al (2014) In vitro effectiveness of the antimicrobial peptide eCATH1 against antibiotic-resistant bacterial pathogens of horses. FEMS Microbiol Lett 350:216–222
Selsted ME, Brown DM, DeLange RJ, Harwig SSL, Lehrer RI (1985) Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 260:4579–4584
Starr CG, Wimley WC (2017) Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes. Biochim Biophys Acta 1859:2319–2326
Starr CG, He J, Wimley WC (2016) Host cell interactions are a significant barrier to the clinical utility of peptide antibiotics. ACS Chem Biol 11:3391–3399
Starr CG, Maderdrut JL, He J, Coy DH, Wimley WC (2018) Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: structure-activity relationships. Peptides 104:35–40
Steiner H, Hultmark D, Engstrom A, Bennich H, Boman HG (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature (London) 292:246–248
Steiner H, Andreu D, Merrifield RB (1988) Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim Biophys Acta 939:260–266
Tran D et al (2002) Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem 277:3079–3084
Wang G, Li X, Wang Z (2016) APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44:D1087–D1093
Werle M, Bernkop-Schnurch A (2006) Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30:351–367
Wiedman G, Kim SY, Zapata-Mercado E, Wimley WC, Hristova K (2016) PH-triggered, macromolecule-sized poration of lipid bilayers by synthetically evolved peptides. J Am Chem Soc 139:937–945
Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5:905–917
Wolfmeier H, Pletzer D, Mansour SC, Hancock REW (2017) New perspectives in biofilm eradication. ACS Infect Dis 4:93–106
Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27–55
Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84:5449–5453
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wimley, W.C. (2019). Application of Synthetic Molecular Evolution to the Discovery of Antimicrobial Peptides. In: Matsuzaki, K. (eds) Antimicrobial Peptides. Advances in Experimental Medicine and Biology, vol 1117. Springer, Singapore. https://doi.org/10.1007/978-981-13-3588-4_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-3588-4_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3587-7
Online ISBN: 978-981-13-3588-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)